2007/2008 |
August 13, 2008 GPC Biotech Reports Financial Results for Second Quarter and First Six Months of 2008 More... |
8. August 2008 GPC Biotech Schedules Conference Call on August 13th to Discuss First Half 2008 Financial Results More... |
6. August 2008 GPC Biotech Reports that Celgene to Terminate Co-Development and License Agreement for Satraplatin More... |
July 25, 2008 GPC Biotech Reports that Marketing Authorization Application for Satraplatin is to be Withdrawn More... |
July 17, 2008 GPC Biotech To Re-Schedule Annual Shareholders’ Meeting More... |
June 24, 2008 GPC Biotech Announces Initiation of NCI-Sponsored Phase 2 Trial of Satraplatin in Patients with Metastatic Hormone-Refractory Prostate Cancer Previously Treated with Docetaxel More... |
June 12, 2008 GPC Biotech Announces Granting of European Patent Related to Satraplatin for Treating Tumors Resistant or Refractory to Taxanes More... |
June 5, 2008 GPC Biotech to Present at Two Upcoming Conferences: 7th Annual Needham Biotechnology & Medical Technology Conference in New York and Piper Jaffray Europe Conference in London More... |
June 2, 2008 Data from Satraplatin SPARC Phase 3 Trial in Patients with Hormone-Refractory Prostate Cancer Progressing after Initial Chemotherapy Presented at 44th ASCO Annual Meeting More... |
June 2, 2008 New Data from Several Satraplatin Clinical Trials in Solid Tumors Presented at 44th ASCO Annual Meeting More... |
May 28, 2008 GPC Biotech Announces Data from Several Satraplatin Clinical Trials to be Presented at ASCO Annual Meeting More... |
May 15, 2008 GPC Biotech Reports Financial Results for First Quarter 2008 More... |
May 9, 2008 GPC Biotech Schedules Conference Call on May 15th to Discuss First Quarter 2008 Financial Results More... |
March 27, 2008 GPC Biotech Reports Financial Results for Fiscal Year 2007 More... |
13. März 2008 GPC Biotech to Present at Cowen and Company 28th Annual Health Care Conference in Boston More... |
March 5, 2008 GPC Biotech to Hold Conference Call on March 27, 2008 to Discuss Year-End 2007 Financial Results More... |
25. February 2008 GPC Biotech Announces Corporate Restructuringand Provides Pipeline Update More... |
January 7, 2008 GPC Biotech to Provide Update on Research and Development Programs at JPMorgan 26th Annual Healthcare Conference in San Francisco More... |
December 20, 2007 GPC Biotech to Present at JPMorgan 26th Annual Healthcare Conference in San Francisco More... |
December 4, 2007 GPC Biotech Appoints Torsten Hombeck as Chief Financial Officer More... |
November 21, 2007 GPC Biotech to Present at 19th Annual Piper Jaffray Health Care Conference in New York More... |
November 15, 2007 GPC Biotech Announces Corporate Restructuring More... |
November 8, 2007 GPC Biotech Reports Financial Results for Third Quarter and First Nine Months of 2007 More... |
November 5, 2007 GPC Biotech Announces Favorable Ruling in Arbitration with Spectrum Pharmaceuticals More... |
November 2, 2007 GPC Biotech Meeting and Conference Call on Third Quarter 2007 Results Scheduled for November 8th More... |
October 30, 2007 GPC Biotech and Pharmion Announce Results of Overall Survival Analysis from the Satraplatin Pivotal Phase 3 Trial More... |
September 20, 2007 GPC Biotech to Present at UBS Global Life Sciences Conference in New York More... |
August 23, 2007 GPC Biotech Announces Restructuring More... |
August 8, 2007 GPC Biotech Reports Financial Results for Second Quarter and First Six Months of 2007 More... |
August 2, 2007 GPC Biotech Schedules Conference Call on August 8th to Discuss First Half 2007 Financial Results More... |
July 30, 2007 GPC Biotech Withdraws Satraplatin NDA Filed for Accelerated Approval More... |
July 27, 2007 GPC Biotech AG Named in Purported Class Action Lawsuit in the United States More... |
July 25, 2007 FDA Oncologic Drugs Advisory Committee Recommends that FDA Wait for Overall Survival Results from Satraplatin Phase 3 Trial More... |
July 20, 2007 GPC Biotech Schedules Conference Call on July 25 to Discuss Oncologic Drugs Advisory Committee (ODAC) Recommendation on Satraplatin More... |
June 26, 2007 GPC Biotech Announces that Partner Pharmion Submits European Marketing Application for Satraplatin More... |
June 25, 2007 GPC Biotech Announces Partnering Agreement for Satraplatin for Japan with Yakult More... |
June 14, 2007 GPC Biotech to Present at Second Annual Piper Jaffray London Health Care Conference More... |
June 8, 2007 GPC Biotech to Present at Two Upcoming Conferences: Goldman Sachs 28th Annual Global Healthcare Conference in California and 6th Annual Needham Biotechnology & Medical Technology Conference in New York |
June 4, 2007 Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting More... |
May 29, 2007 GPC Biotech to Host Investor Event in Chicago on June 4th during ASCO Annual Meeting More... |
May 25, 2007 GPC Biotech Announces Election of Donald Soltysiak to Supervisory Board More... |
May 21, 2007 Additional Efficacy Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at Annual Meeting of American Urological Association More... |
May 15, 2007 GPC Biotech’s Satraplatin NDA to be Reviewed by ODAC Panel on July 24, 2007 More... |
May 15, 2007 GPC Biotech Reports Financial Results for the First Quarter of 2007 More... |
May 9, 2007 GPC Biotech to Present at Two Upcoming Conferences: Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference in Monte Carlo and Citigroup Healthcare Conference in New York City |
May 5, 2007 GPC Biotech Schedules Conference Call on May 15th to Discuss First Quarter 2007 Financial Results More... |
May 3, 2007 GPC Biotech Consolidates Drug Discovery Activities More... |
April 16, 2007 FDA Accepts GPC Biotech’s Satraplatin NDA for Filing and Grants Priority Review Status More... |
March 22, 2007 Additional Data from Satraplatin SPARC Phase 3 Trial Presented at European Association of Urology Congress More... |
March 16, 2007 GPC Biotech to Present at Lehman Brothers Tenth Annual Global Healthcare Conference in Florida More... |
March 15, 2007 GPC Biotech Reports Financial Results for Fiscal Year 2006 More... |
March 9, 2007 GPC Biotech Meeting and Conference Call on Business Results for the Fiscal Year 2006 Scheduled for March 15 More... |
February 23, 2007 Satraplatin Shown to Significantly Reduce Risk of Disease Progression in Advanced Hormone-Refractory Prostate Cancer Patients More... |
February 21, 2007 GPC Biotech Launches Expanded Access Program for Oncology Drug Candidate Satraplatin in the U.S. More... |
February 16, 2007 GPC Biotech Schedules Conference Call to Discuss Results from the Satraplatin Phase 3 Trial Being Presented at the ASCO Prostate Cancer Symposium in Orlando, Florida More... |
February 16, 2007 GPC Biotech Submits NDA for Lead Oncology Drug Candidate Satraplatin More... |
February 5, 2007 GPC Biotech to Present at 9th Annual BIO CEO & Investor Conference in New York City More... |
January 24, 2007 GPC Biotech Raises € 33.6 Million (~$43.7) in Private Placement More... |
January 24, 2007 GPC Biotech Announces Share Capital Issuance of up to 1,564,587 Shares More... |
November 9, 2006 GPC Biotech Reports Financial Results for Third Quarter and First Nine Months of 2006 More... |
